Milithin (Lithium Carbonate)

Lithium carbonate, the active ingredient in Milithin, is a mood stabilizer presented as an oral tablet for oral use. It is employed to treat bipolar disorder and related manic episodes in adult patients. GNH USA supplies Milithin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Milithin, a lithium carbonate formulation, acts on mood regulation pathways and is used in the management of bipolar disorder and related conditions. - Bipolar disorder: stabilises mood and reduces the frequency of depressive and manic episodes. - Mania: controls acute manic symptoms and helps maintain remission. - Maintenance therapy: supports long‑term mood stability to prevent relapse.

Lithium carbonate may cause a range of adverse reactions that vary in frequency and severity.

Common Side Effects: - Tremor: mild to moderate shaking, often in the hands. - Increased thirst and urination: polyuria and polydipsia are frequently reported. - Gastrointestinal upset: nausea, diarrhoea or abdominal discomfort. - Weight gain: modest increase in body weight over time.

Serious or Rare Side Effects: - Thyroid dysfunction: hypothyroidism requiring monitoring and possible treatment. - Renal impairment: reduced kidney function that may be irreversible with prolonged use.

When prescribing Milithin, clinicians should consider several safety measures. - Serum level monitoring: maintain lithium concentrations within the therapeutic window. - Renal function assessment: evaluate baseline and periodic kidney function. - Thyroid function assessment: check thyroid hormones before and during therapy. - Hydration status: advise patients to avoid dehydration and excessive salt loss. - Elderly patients: use lower doses and monitor closely for toxicity. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Lithium carbonate can interact with various medications, requiring careful management.

Major Interactions (Avoid): - ACE inhibitors: may increase lithium levels and risk of toxicity. - NSAIDs: can reduce renal clearance of lithium, raising serum concentrations. - Thiazide diuretics: potentiate lithium accumulation and toxicity. - SSRIs: combined use may increase the risk of serotonin syndrome. - Carbamazepine: may lower lithium levels, reducing efficacy.

Moderate Interactions (Monitor Closely): - Antihypertensives: may enhance lithium's blood pressure effects. - Caffeine: can affect lithium excretion and serum levels. - Other mood stabilizers: may require dose adjustments. - Diuretics (non‑thiazide): monitor renal function and lithium levels. - Anticholinergic agents: may exacerbate cognitive side effects.